Abstract
Nanotechnology is a rapidly emerging field of great interest and promise. As new materials are developed and commercialized, hazard information also needs to be generated to reassure regulators, workers, and consumers that these materials can be used safely. The biological properties of nanomaterials are closely tied to the physical characteristics, including size, shape, dissolution rate, agglomeration state, and surface chemistry, to name a few. Furthermore, these properties can be altered by the medium used to suspend or disperse these water-insoluble particles. However, the current toxicology literature lacks much of the characterization information that allows toxicologists and regulators to develop “rules of thumb” that could be used to assess potential hazards. To effectively develop these rules, toxicologists need to know the characteristics of the particle that interacts with the biological system. This void leaves the scientific community with no options other than to evaluate all materials for all potential hazards. Lack of characterization could also lead to different laboratories reporting discordant results on seemingly the same test material because of subtle differences in the particle or differences in the dispersion medium used that resulted in altered properties and toxicity of the particle. For these reasons, good characterization using a minimal characterization data set should accompany and be required of all scientific publications on nanomaterials.
Similar content being viewed by others
References
Murdock RC et al (2008) Toxicol Sci 101(2):239–253
Guo L et al (2008) Small 4(6):721–727
Holsapple MP et al (2005) Toxicol Sci 88(1):12–17
Oberdorster G et al (2005) Part Fibre Toxicol 2:8
Scientific Committee on Emerging and Newly Identified Health Risks (SCENIHR) (2006) The appropriateness of existing methodologies to assess the potential risk associated with engineered and adventitious products of nanotechnology. http://ec.europa.eu/health/ph_risk/committees/04_scenihr/docs/scenihr_o_003b.pdf
Environmental Defense Fund and DuPont (2007) Nano risk framework. http://nanoriskframework.com/page.cfm?tagID=1095
Borm P et al (2006) Toxicol Sci 90(1):23–32
Xia T et al (2008) ACS Nano 2(10):2121–2134
Hardman R (2006) Environ Health Perspect 114(2):165–172
Poland CA et al (2008) Nat Nanotechnol 3(7):423–428
Maxim LD et al (2006) Regul Toxicol Pharmacol 46(1):42–62
Ma-Hock L et al (2007) Inhal Toxicol 19(10):833–848
Baron PA et al (2008) Inhal Toxicol 20(8):751–760
Oberdorster G, Oberdorster E, Oberdorster J (2005) Environ Health Perspect 113(7):823–839
Warheit DB et al (2004) Toxicol Sci 77(1):117–125
Sager TM, Castranova V (2009) Part Fibre Toxicol 6:5
Oberdorster G et al (1990) J Aerosol Sci 21:384–387
Glory J et al (2007) J Nanosci Nanotechnol 7(10):3458–3462
Rogers K et al (2009) In: The toxicologist—Society of Toxicology annual meeting 2009 abstracts
Sager TM, Kommineni C, Castranova V (2008) Part Fibre Toxicol 5:17
Stoeger T et al (2006) Environ Health Perspect 114(3):328–333
Wittmaack K (2007) Environ Health Perspect 115(2):187–194
Warheit DB et al (2007) Toxicol Sci 95(1):270–280
Warheit DB et al (2006) Toxicol Sci 91(1):227–236
Oberdorster G, Oberdorster E, Oberdorster J (2007) Environ Health Perspect 115(6):A290
Stoeger T et al (2007) Environ Health Perspect 115(6):A290–291 author reply A291–292
Wittmaack K (2007) Environ Health Perspect 115(6):A290–291 author reply A291–292
Warheit DB et al (2007) Toxicol Lett 171(3):99–110
Ahamed M et al (2008) Toxicol Appl Pharmacol 233(3):404–410
Hauck TS, Ghazani AA, Chan WC (2008) Small 4(1):153–159
Jani P et al (1990) J Pharm Pharmacol 42(12):821–826
Jani PU et al (1996) J Drug Target 4(2):87–93
Florence AT et al (1995) J Drug Target 3(1):65–70
Monteiro-Riviere NA, Inman AO, Zhang LW (2009) Toxicol Appl Pharmacol 234(2):222–235
Donaldson K et al (2009) Part Fibre Toxicol 6:13
Renwick LC et al (2004) Occup Environ Med 61(5):442–447
Barlow PG et al (2005) Part Fibre Toxicol 2:11
Brunner TJ et al (2006) Environ Sci Technol 40(14):4374–4381
Sayes CM, Warheit D (2008) Int J Nanotechnol 5(1):15–29
Barnes CA et al (2008) Nano Lett 8(9):3069–3074
Singh N et al (2009) Biomaterials 30(23–24):3891–3914
Warheit DB (2008) Toxicol Sci 101(2):183–185
Powers KW et al (2006) Toxicol Sci 90(2):296–303
Erickson BE (2008) Chem Eng News 86(50):25–26
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Boverhof, D.R., David, R.M. Nanomaterial characterization: considerations and needs for hazard assessment and safety evaluation. Anal Bioanal Chem 396, 953–961 (2010). https://doi.org/10.1007/s00216-009-3103-3
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00216-009-3103-3